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Abstract
Background: New diagnostic tools for malaria are required owing to the changing epidemiology of malaria,
particularly among pregnant women in sub-Saharan Africa. Real-time PCR assays targeting Plasmodium falciparum
lactate dehydrogenase (pfldh) gene may facilitate the identification of a high proportion of pregnant women with
a P. falciparum parasitaemia below the threshold of microscopy. These molecular methods will enable further
studies on the effects of these submicroscopic infections on maternal health and birth outcomes.
Methods: The pfldh real-time PCR assay and conventional microscopy were compared for the detection of
P. falciparum from dried blood spots and blood smears collected from the peripheral blood of 475 Malawian
women at delivery. A cycle threshold (Ct) of the real-time PCR was determined optimizing the sensitivity and
specificity of the pfldh PCR assay compared to microscopy. A real-time PCR species-specific assay was applied to
identify the contribution to malaria infections of three Plasmodium species (P. falciparum P. ovale and P. malariae)
in 44 discordant smear and pfldh PCR assay results.
Results: Of the 475 women, P. falciparum was detected in 11 (2.3%) by microscopy and in 51 (10.7%) by real-time
PCR; compared to microscopy, the sensitivity of real-time PCR was 90.9% and the specificity 91.2%. If a Ct value of
38 was used as a cut-off, specificity improved to 94.6% with no change in sensitivity. The real-time PCR species-
specific assay detected P. falciparum alone in all but four samples: two samples were mixed infections with P.
falciparum and P. malariae, one was a pure P. malariae infection and one was a pfldh PCR assay-positive/species-
specific assay-negative sample. Of three P. malariae infections detected by microscopy, only one was confirmed by
the species-specific assay.
Conclusions: Although microscopy remains the most appropriate method for clinical malaria diagnosis in field
settings, molecular diagnostics such as real-time PCR offer a more reliable means to detect malaria parasites,
particularly at low levels. Determination of the possible contribution of these submicroscopic infections to poor
birth outcomes and maternal health is critical. For future studies to investigate these effects, this pfldh real-time
PCR assay offers a reliable detection method.
Background
Malaria in pregnancy produces substantial maternal and
infant morbidity and mortality in sub-Saharan Africa
[1]. Compared with non-pregnant women, pregnant
women - especially primigravidae - are at particularly
high risk for Plasmodium falciparum infection. In
mothers, malaria contributes to maternal anaemia and
peripartum morbidity, while infants suffer from low
birth weight resulting both from intrauterine growth
retardation and pre-term delivery; up to 200,000 infant
deaths every year are attributed to malaria in pregnancy
[1]. Consequently, most malaria-endemic countries in
sub-Saharan Africa administer intermittent preventive
therapy in pregnancy (IPTp) with two to three doses of
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sulphadoxine-pyrimethamine (SP) to all pregnant
women. IPTp substantially reduces malaria during preg-
nancy and improves maternal and infant health out-
comes [2-6]. Unfortunately, parasite resistance to SP is
prevalent in many African countries and endangers the
drug’s utility as IPTp [7,8].
Submicroscopic infections are common during preg-
nancy [9,10]. Molecular methods are, on the average,
capable of finding approximately twice as many infec-
tions as microscopy [11]. However, the epidemiology
and clinical significance of submicroscopic malaria
infections during pregnancy have not been well studied.
In this cross-sectional study, two malaria diagnostic
methods, a real-time PCR assay targeting the P. falci-
parum lactate dehydrogenase gene (pfldh) and conven-
tional microscopy, were compared among women
delivering at the local health facilities in or near Lung-
wena, Malawi, where malaria is holoendemic. The goals
of this study were twofold: 1) to evaluate whether real-
time PCR increases detection of P. falciparum infections
in Malawian pregnant women compared to microscopy,
and 2) to determine a real-time PCR cycle threshold
(Ct) that optimizes sensitivity and specificity compared
to microscopy. In addition, in this study a real-time
PCR species-specific assay was applied to identify the
contribution to malaria infections during pregnancy of
non-falciparum species.
Methods
Study area and population
The samples were collected as part of the Lungwena
Antenatal Intervention Study (LAIS), which is described
in detail elsewhere [12]. Briefly, the LAIS enrolled 1320
women in the second trimester at a single rural health
centre in the Mangochi district in southern Malawi
between December 2003 and October 2006. This is a
hot, dry and low-lying rural area and the population is
mainly engaged in subsistence farming and fishing.
Malaria is holoendemic in Malawi despite the common
use of bed nets in local households. The rainy season is
between December and March [13]. The women
received antenatal care and IPTp with either two doses
of SP, monthly SP, or monthly SP combined with two
doses of azithromycin and were followed longitudinally
until one month after delivery. The trial was performed
according to Good Clinical Practice guidelines (ICH-
GCP) and its protocol was approved by the College of
Medicine Research and Ethics Committee, University of
Malawi and the Ethical Committee of Pirkanmaa Hospi-
tal District, Finland.
Sample collection and preparation
Maternal peripheral venous blood samples were col-
lected as dried blood spots and blood films briefly after
delivery from the women who gave birth at the local
health facilities. Giemsa-stained thin and thick blood
films were prepared and subsequently interpreted by an
experienced microscopist in a local research laboratory.
Thick smears were defined as negative if 200 high-
power fields were free of all malaria species. Addition-
ally, the maternal venous peripheral blood was prepared
as dried blood spots: two 50 μl aliquots of blood from
the same patient were applied to Whatman FTA filter
paper (Whatman plc, Maidstone, UK), air-dried immedi-
ately and placed in individually sealed plastic bags with
desiccant. The sample bags were stored in dry condi-
tions at room temperature prior to transport to the Uni-
versity of Tampere, Finland.
DNA extraction
Blood spots were cut from each filter paper using scis-
sors and deposited into individual 1.5 mL tubes. Scissors
were sterilized twice with 100% ethanol and flame after
each sample. Genomic DNA (gDNA) was extracted
from the blood spots using the BioRobot M48 worksta-
tion (Qiagen, Valencia, CA, USA). The DNA Mini M48
Kit (Qiagen) protocol “Isolation of DNA from dried
blood” was followed with these exceptions: the sample
disk was incubated with 760 μl of buffer MTL(1) in con-
tinuous mixing (130 rpm) at 70°C for 1 hour; and before
starting the isolation programme the filter paper disk
was removed from the sample solution. Genomic DNA
was eluted into 100 μl of elution buffer for use in real-
time PCR assays.
Real-time PCR testing
All gDNA samples from maternal peripheral blood were
amplified in an assay targeting the P. falciparum lactate
dehydrogenase gene (pfldh) [14] (see Table 1 for primer
and probe sequences). Reaction volumes were 25 μl
each, consisting of 12.5 μl Universal PCR Master Mix
(Applied Biosystems), 1 μl of gDNA, forward and
reverse primers at 250 nM each, probe at 300 nM, and
molecular-grade water. All reactions were run in dupli-
cate on an ABI PRISM 7000 Real-Time System (Applied
Biosystems, Foster City, CA, USA). The cycling condi-
tions were: 50°C for 2 min, 95°C for 10 min, and 40
cycles of 95°C for 15 s followed by 60°C for 1 min. Each
reaction plate included four serial dilutions (10, 1, 0.1,
0.01 ng/μl) of P. falciparum 3D7 genomic DNA
extracted from lab-cultured parasites [15] as positive
controls and a negative control with molecular-grade
water in place of DNA, all in duplicate. For each plate,
threshold lines were set manually and mean Ct was cal-
culated for each amplified duplicate. Samples were con-
sidered P. falciparum-positive if both amplification
curves reached the threshold line. Reactions with only
one amplification curve reaching the threshold line or
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with a Ct value between 39 and 40 were repeated in
duplicate with a template volume of 2 μl. Ct values were
plotted against the logarithmic concentrations of 3D7
control gDNA and correlation coefficient (R2) values
and sample concentrations were calculated.
To determine the specificity of the pfldh PCR assay,
all samples with discordant microscopy and real-time
PCR results were specified in a real-time PCR assay tar-
geting species-specific sequences of the ribosomal DNA
(rDNA) of P. falciparum, P. ovale, and P. malariae. Pri-
mer and probe sequences were adapted from an earlier
study [16] (Table 1). The assay consisted of two parallel
duplex reactions employing minor-groove binding
(MGB) probes labeled with FAM or VIC fluorophores
to detect P. falciparum and P. ovale in one reaction and
P. malariae and a human gene (as a positive control) in
the second [16].
Statistical analyses
The results from pfldh PCR assay were compared to
microscopy results. The prevalence of malaria infections
by each method was compared by month. Using micro-
scopy as the ‘gold standard’, we calculated sensitivity
(number of true positives/(number of true positives +
number of false negatives)) and specificity (number of
true negatives/(number of true negatives + number of
false positives)), as well as positive and negative predic-
tive values for qualitative detection of P. falciparum
infections by the pfldh PCR assay. In addition, the opti-
mal Ct cut-off point for pfldh PCR assay was evaluated
by calculating sensitivity and specificity for different Ct
cut-off points and constructing a receiver operating
characteristic (ROC) curve; the area under curve (AUC)
was calculated from this figure. To analyse the effect of
the detection of parasites at delivery on birth outcomes,
pairwise comparisons between groups of women (based
on P. falciparum detection) were made using the stu-
dent’s t-test and the chi-squared test for continuous and
categorical variables, respectively. Comparisons were
two-tailed, and a p-value of < 0.05 was considered sig-
nificant. All statistical analyses were performed in MS
Excel (v 12.2.5 (2008), Microsoft, Redmond, WA, USA).
Results
Study population
Of 1,320 women enrolled, 491 gave birth at the local
health facilities (829 women delivered at home and were
excluded from further analysis). Of these 491 partici-
pants, a further sixteen women were excluded because
of the lack of dried blood spots (n = 6), microscopy data
(n = 9) or both (n = 1), resulting in a study population
of 475 women. The characteristics of these 475 partici-
pants are presented in Table 2.
Sensitivity and specificity
Of 475 women at delivery, P. falciparum was detected in
11 (2.3%) by microscopy. Three additional patients had
P. malariae monoinfections detected microscopically. In
contrast, 51 (10.7%) samples were positive for P. falci-
parum by the pfldh PCR assay (Table 3). Of the 11
Table 1 Primer and probe sequences
Assay Reagent Sequencec
Pfldh Primersa P. falciparum LDH forward ACG ATT TGG CTG GAG CAG AT
P. falciparum LDH reverse TCT CTA TTC CAT TCT TTG TCA CTC TTT C
Probeb TaqMan probe (P. falciparum LDH) FAM-AGT AAT AGT AAC AGC TGG ATT TAC CAA GGC CCC A-TAMRA
Species-specific Primersa P. falciparum 18 S rDNA forward ATT GCT TTT GAG AGG TTT TGT TAC TTT
P. falciparum 18 S rDNA reverse GCT GTA GTA TTC AAA CAC AAT GAA CTC AA
P. ovale 18 S rDNA forward CCG ACT AGG TTT TGG ATG AAA GAT TTT T
P. ovale 18 S rDNA reverse CAA CCC AAA GAC TTT GAT TTC TCA TAA
P. malariae 18 S rDNA forward AGT TAA GGG AGT GAA GAC GAT CAG A
P. malariae 18 S rDNA reverse CAA CCC AAA GAC TTT GAT TTC TCA TAA
Human GAPDH forward CCT CCC GCT TCG CTC TCT
Human GAPDH reverse GCT GGC GAC GCA AAA GA
MGB probesb P. falciparum FAM-CAT AAC AGA CGG GTA GTC AT
P. ovale VIC-CGA AAG GAA TTT TCT TAT T
P. malariae FAM-ATG AGT GTT TCT TTT AGA TAG C
Human GAPDH VIC-CCT CCT GTT CGA CAG TCA GCC GC
aSynthesized by MWG/Operon Biotech (High Point, NC) and re-suspended in molecular-grade water. LDH, lactate dehydrogenase. GAPDH, glyceraldehyde-3-
phosphate dehydrogenase.
bSynthesized by Applied Biosystems (Foster City, CA) and diluted in Tris-EDTA Buffer (FisherBioTech, Fair Lawn, NJ). LDH, lactate dehydrogenase. GAPDH,
glyceraldehyde-3-phosphate dehydrogenase.
cFAM and VIC denote fluorescent dyes. TAMRA denotes the quencher 6-carboxytetramethylrhodamine. MGB, minor groove binding probes.
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samples found to have P. falciparum by microscopy, 10
were positive in the pfldh PCR assay. Of the 464 micro-
scopy-negative samples, 41 were positive in the pfldh
PCR assay. Compared to microscopy, the sensitivity of
real-time PCR for detection of P. falciparum was 90.9%
and the specificity 91.2%. Submicroscopic infections
were most prevalent during and after the rainy season
in January-April, while microscopic malaria prevalence
peaked only at the earlier part of the rainy season (Janu-
ary and February) (Figure 1). Thus, for example, there
were 9 cases of P. falciparum by pfldh PCR, vs 1 by
microscopy in April, while in July PCR and microscopy
detected the same number of infections (one each).
Ct cut-off points and ROC curve
The AUC of the ROC curve was 0.89. Based on the
serial sensitivities and specificities at various Ct cut-off
points and the ROC curve (Figure 2), a Ct cut-off of 38
optimized sensitivity and specificity at 90.9% and 94.6%,
respectively. At this level, the positive predictive and
negative predictive value were 28.6% and 99.8%, respec-
tively. Notably, the ROC curve failed to reach 100 per-
cent sensitivity because of one pfldh PCR-negative/
microscopy-positive P. falciparum infection.
Real-time PCR species-specific assay
Of the 475 women, 44 samples were analyzed in the
species-specific assay, including all submicroscopic
parasitaemia (41), one pfldh PCR-negative/microscopy-
positive P. falciparum infection, and two pfldh PCR-
negative/microscopy-positive P. malariae samples (Table
4). From the 41 submicroscopic samples, 40 P. falci-
parum infections were confirmed in the species-specific
assay, including two samples that were mixed infections
with P. falciparum and P. malariae. One sample was
pfldh PCR-positive but negative in the species-specific
assay.
Of three patients diagnosed with P. malariae by
microscopy, only one was positive in the species-specific
assay. Furthermore, the assay detected two P. malariae -
P. falciparum co-infections which were aparasitemic by
microscopy (Table 4). Thus, although numbers were
small, there is a very poor concordance between micro-
scopy and our real-time PCR assay for the diagnosis of
P. malariae.
Plasmodium falciparum detection and birth outcomes
Of 459 newborns, 56 (12.2%) were low birth weight,
defined as weight < 2500 g. There were no significant
differences in the prevalence of low birth weight new-
borns between women with a smear-positive parasitae-
mia (10%), women with a submicroscopic parasitaemia
(19.5%), and aparasitaemic women (11.5%; Table 5).
Similarly, there were no significant differences between
these groups on mean birth weight, mean gestational
age at delivery, or the proportion of preterm birth.
Discussion
The prevalence of submicroscopic P. falciparum infec-
tions was substantial among pregnant women at delivery
in our cohort in Malawi. Compared with microscopy, a
real-time PCR assay targeting the pfldh gene detected
more P. falciparum infections: 11 (2.3%) women were
microscopy-positive and 51 (10.7%) were real-time PCR
positive. Compared with microscopy, the sensitivity and
Table 2 Characteristics of 475 women at enrollment and
the time of delivery
Enrollment, second trimester: n = 475
Age (years; mean, SD) 24 (6.3)
BMI (mean, SD) 21.9 (2.2)
Gravidity:
Primigravidae (%) 28.6
Secundigravidae (%) 17.9
Multigravidae (%) 53.5
Bed net use by mother in enrollment (%) 60
HIV infection (%) 12.4
Delivery:
Maternal haemoglobin (g/dL; mean, SD) 11.4 (1.9)*
Maternal anaemia** (%) 31.3*
Maternal microscopy result for malaria***:
P. falciparum (%) 2.3
P. vivax (%) 0
P. ovale (%) 0
P. malariae (%) 0.6
Season of birth:
Jan - March (%) 16.8
April - June (%) 29.9
July - Sept (%) 31.2
Oct - Dec (%) 22.1
Estimated gestational age of the child (weeks; mean, SD) 38.8 (1.8)
BMI, body mass index; *, n = 451; **, haemoglobin < 11.0 g/dL (WHO
guideline 1972, ‘Nutritional Anaemias’); ***, examination from Giemsa stained
thin and thick blood film from maternal peripheral blood.
Table 3 Comparison of P. falciparum parasites in
maternal peripheral blood at delivery by the pfldh real-
time PCR assay and microscopic thin and thick blood
film examination
Gold standard:
Test result: Microscopy
pfldh real-time PCR assay + −
+ 10 41 51 (10.7%)
− 1 423 424 (89.3%)
11 (2.3%) 464 (97.7%) Total
475 (100%)
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specificity of our real-time PCR assay were 90.9% and
91.2% respectively. Real-time PCR can be a sensitive
tool to detect low-level malaria infections and thus to
evaluate the effect of these infections on birth outcomes.
Additionally, we found few infections with non-falci-
parum species in our pregnancy cohort.
This detection of a large number of submicroscopic
infectious by real-time PCR is similar to previous studies
Figure 1 Comparison of P. falciparum infections detected by microscopy and the pfldh real-time PCR assay at delivery by calendar
months.
Figure 2 ROC-curve calculated from the sensitivity and 1-specificity of the pfldh real-time PCR assay. TPR, true positive rate, FPR, false
positive rate.
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of malaria in pregnancy [9,10]. When testing both per-
ipheral and placental blood of pregnant women in
Gabon at delivery with an assay targeting Plasmodia
rDNA, [17] a real-time PCR detected three-fold more
P. falciparum infections than microscopy (10% by
microscopy and 31% by real-time PCR). Similarly, in a
Kenyan study [18], four-fold more parasitaemia were
detected at delivery with a real-time PCR assay com-
pared with microscopy (37.9% and 9.4%, respectively).
Submicroscopic parasitaemia detected by real-time PCR
assays have been detected with similar frequency as ours
at earlier gestational ages in studies in both the Sudan
[19] and Mozambique [9]. These data, which indicate
that the prevalence of submicroscopic infections is simi-
lar both early in pregnancy and at delivery, suggest that
the good adherence to IPTp, as was common in our
study, may not substantially affect the prevalence of
these low-level malaria infections.
Submicroscopic infections in the general population
are significant in serving as a reservoir of parasites to
drive transmission intensity [11], but they usually have
few consequences for the individual. In this study, para-
sitaemia at delivery - as detected by either blood smear
or the pfldh PCR assay - was not associated with poor
birth outcomes compared with aparasitaemic women.
Previous studies have produced conflicting data on the
effect of these infections on maternal or fetal health out-
comes. Two earlier reports found no association
between low-birth weight and submicroscopic infections
in peripheral blood as detected by either rapid antigen
test or PCR assays [20,21]. In contrast, real-time PCR
positivity was correlated with lower birth weight in a
cohort of Kenyan women, though it is unclear if this dif-
ference was accounted for by the smear-positive or by
the submicroscopic infections [18]. Only one study in
Gabon [17] has demonstrated a clear association
between submicroscopic parasitaemia at delivery and
low-birth weight, and this has yet to be confirmed in
subsequent studies. Additionally, maternal anaemia has
been associated with submicroscopic infections in some
studies [9,17,22] but not in others [23,24]. Taken
together, evidence is suggestive that submicroscopic
parasitaemia at delivery is likely associated with deleter-
ious maternal and fetal health outcomes, though the
overall low prevalence of parasitaemia at delivery likely
prevented the detection of deleterious consequences.
Table 4 Detection of malaria parasites by microscopy, the pfldh real-time PCR assay and the species-specific real-time
PCR assay
Organism(s) detected by each method (No. of samples)
Malaria-causing speciesa Microscopy, thin and thick blood smears Real-Time PCR, pfldh assay Real-Time PCR, species-specific assayb
P. falciparum P. falciparum (11) P. falciparum (10) –
Negative (1) Negative (1)
Non- P. falciparum P. malariae (3) P. falciparum (1) P. falciparum (1)
Negative (2) P. malariae (1)
Negative (1)
Negative Negative (461) P. falciparum (40) P. falciparum (37)
P. falc. + P. malariae (2)
Negative (1)
Negative (421) –
Total 475 475 44
aMalaria species are classified according to the diagnosis obtained from the blood smear examination.
bSpecies-specific assay is conducted for all specimens with discordant smear and pfldh PCR assay results (44).
Table 5 Clinical outcomes and the detection of P. falciparum at deliverya
I II III p-valueb
Microscopy-positive/pfldh-
positive
(n = 10)
Microscopy-negative/pfldh-
positive
(n = 41)
Both tests
negative
(n = 408)
I v. III II v. III
Birth weight, g, mean (SD) 2,863 (425) 2,927 (445) 2,954 (492) 0.561 0.736
Low birth weight, % (No.) 10 (1) 19.5 (8) 11.5 (47) 1 0.138
Gestational age at delivery, weeks,
mean (SD)
39.2 (2.5) 38.7 (1.6) 38.8 (1.8)c 0.507 0.835
Preterm delivery, % (No.) 10 (1) 14.6 (6) 11.6 (49) c 1 0.611
aSD: standard deviation. Low birth weight is defined as <2500 g, and preterm delivery as <37 weeks.
bDetermined by student’s t-test or chi-squared test for continuous and categorical variables, respectively.
cn = 423.
Rantala et al. Malaria Journal 2010, 9:269
http://www.malariajournal.com/content/9/1/269
Page 6 of 9
More definitive characterization of these effects requires
larger studies and a simple and reliable tool to detect
such parasitaemia.
The pfldh real-time PCR assay we employed is highly
sensitive and specific for P. falciparum infections, and
offers several diagnostic advantages to conventional
microscopy. Drying blood on filter paper is an effective
form of DNA storage and samples prepared in this man-
ner are cheap and safe to transport [25]. DNA extrac-
tion from dried blood spots is relatively easy and rapid
to perform, and automated extraction minimizes the
risk of contamination. In general, real-time PCR assays
offer specific advantages over other PCR-based chemis-
tries: they are less labor-intensive; they are performed in
closed systems which minimize the risk of post-amplifi-
cation contamination; assay results can be obtained in a
relatively short period of time; and the assay design is
automated and is well-suited to multipurpose studies
[26-28]. Additionally, the pfldh PCR assay can be used
to detect parasitaemia from peripheral blood as well as
placental or cord blood.
This study has several limitations. First, though the
pfldh PCR assay can theoretically quantify the amount of
P. falciparum gDNA, slight variations in blood spot size
and efficiency of extraction prevent reliable quantitation
of parasite burden. Though it is likely that the infections
detected only by the assay were, in fact, “submicro-
scopic”, they may also be the result of poorly-sensitive
microscopy. Moreover, microscopy can be an imperfect
reference standard used for malaria diagnosis, and this
study did not have microscopy quality control [29,30].
Additionally, the pfldh PCR assay, though simple and
easy to perform, detects only P. falciparum infections.
However, a species-specific assay was employed in a
directed fashion to account for this, and the contribution
of other species to infections at delivery was low. Plasmo-
dium vivax was not addressed due to its rarity in sub-
Saharan Africa [31]. Finally, due to participants who did
not deliver at local health facilities, the study population
may not be representative of all pregnant women with
malaria at the study site, and its generalizability to other
geographic areas is difficult to predict.
New diagnostic tools may be required owing to the
changing epidemiology of malaria. In 1996, the preva-
lence of microscopy-positive P. falciparum malaria was
26% at delivery in a study similar to ours in Malawi
[32], and in this cohort it was only 2.3%. This decrease
in prevalence, which is temporally associated with
increased utilization of prevention measures such as bed
nets and IPTp, will impact the predictive value of blood
smear results. Specifically, with our pfldh PCR assay as
the reference, the sensitivity of microscopy was only
20% (10/51) and the positive predictive value was 91%
(10/11). Further decline in prevalence will diminish the
positive predictive value, necessitating a more sensitive
method for detection to establish the presence of parasi-
taemia as a possible risk factor for poor birth outcomes.
Microscopy remains the most practical diagnostic tool
in malaria-endemic areas, but its use as a ‘gold standard’
may produce misleading results in clinical trials
[26,29,33,34]. Good-quality microscopy requires proper
blood film preparation, staining, and reading by techni-
cians with substantial expertise, and the operating char-
acteristics of microscopy vary widely in endemic areas
[2]. When compared with molecular diagnostics for
malaria, microscopy readings frequently exhibit substan-
tial discordance, producing both false-negative readings
(as would be expected for submicroscopic parasitaemia)
as well as false-positive readings, which can significantly
impact the results of clinical trials [29]. For these reasons,
molecular diagnostics may offer a more reliable means to
detect malaria parasites in clinical research studies.
The added utility of more sensitive diagnostic tools
such as PCR may vary seasonally according to the
malaria transmission season. In this study, molecular
detection of malaria yielded the greatest diagnostic value
in the months at the end of the rainy season, when
malaria transmission is waning, and detected few infec-
tions during the dry, low-transmission season. Because
molecular testing is resource-intensive, a parsimonious
approach to its application could focus on this period of
declining transmission, when the added diagnostic value
is highest.
Malaria control programmes that employ insecticide-
treated bed nets and IPTp have significantly reduced the
incidence of malaria during pregnancy, but more sensi-
tive parasite detection methods have demonstrated a
large pool of submicroscopic infections which may have
negative consequences for mother and child. Determin-
ing the contribution of these submicroscopic infections
to poor birth outcomes is critical. To this end, simple
and reliable methods to detect these infections are
essential, and we believe the pfldh PCR assay described
herein is well-suited to future studies of submicroscopic
malaria infections during pregnancy.
Conclusions
Although microscopy remains the most appropriate
method for clinical malaria diagnosis in field settings,
molecular diagnostics such as real-time PCR offer a
more reliable means to detect malaria parasites, particu-
larly at low levels. Determination of the contribution of
these submicroscopic infections to poor birth outcomes
and maternal health is critical. For future studies to
investigate these effects, the pfldh real-time PCR assay
described herein offers a reliable detection method.
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